3 Brierley M M, Fish E N. Stats: Multifaceted regulators of transcription. J Interfer Cytok Res, 2005, 25: 733-744
[2]
4 Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol, 2011, 30: 16-34
[3]
6 Brown J, Wang H, Hajishengallis G N, et al. TLR-signaling networks: An integration of adaptor molecules, kinases, and cross-talk. J Dent Res, 2011, 90: 417-427
[4]
11 Tseng P H, Matsuzawa A, Zhang W, et al. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of typeⅠinterferons and proinflammatory cytokines. Nat Immunol, 2010, 11: 70-75
[5]
17 Thompson A J V, Locarnini S A. Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol Cell Biol, 2007, 85: 435-445
[6]
19 Yoneyama M, Fujita T. Structural mechanism of RNA recognition by the RIG-Ⅰ-like receptors. Immunity, 2008, 29: 178-181
[7]
21 Hornung V, Ellegast J, Kim S, et al. 5′-Triphosphate RNA is the ligand for RIG-Ⅰ. Science, 2006, 314: 994-997
[8]
23 Satoh T, Kato H, Kumagai Y, et al. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci USA, 2010, 107: 1512-1517
[9]
24 Okabe Y, Sano T, Nagata S. Regulation of the innate immune response by threonine-phosphatase of eyes absent. Nature, 2009, 460: 520-524
[10]
25 Zeng W, Sun L, Jiang X, et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell, 2010, 141: 315-330
[11]
27 Jounai N, Takeshita F, Kobiyama K, et al. The Atg5-Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci USA, 2007, 104: 1-6
[12]
28 Sun W, Li Y, Chen L, et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc Natl Acad Sci USA, 2009, 106: 8653-8658
[13]
31 Barber G N. Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr Opin Immunol, 2011, 23: 10-20
[14]
32 Chien Y, Kim S, Bumeister R, et al. RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell, 2006, 127: 157-170
[15]
36 Ichinohe T, Pang I K, Iwasaki A. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat Immunol, 2010, 11: 404-410
[16]
37 Zhao Y, Yang J, Shi J, et al. The NLRC4 inflammasome receptors for bacterial flagellin and type Ⅲ secretion apparatus. Nature, 2011, 477: 596-600
[17]
38 Hsu L C, Ali S R, Mcgillivray S, et al. A NOD-NALP1 complex mediates caspase-1-dependent IL-1 secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci USA, 2008, 105: 7803-7808
[18]
39 Bürckstümmer T, Baumann C, Blüml S, et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol, 2009, 10: 266-272
[19]
41 Hornung V, Ablasser A, Charrel-Dennis M, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature, 2009, 458: 514-518
[20]
42 Roberts T L, Idris A, Dunn J A, et al. HIN-200 proteins regulate caspase. Science, 2009, 115: 2007-2010
[21]
43 Aaronson D S, Horvath C M. A road map for those who don't know JAK-STAT. Science, 2002, 296: 1653-1655
[22]
44 Chapoval S, Dasgupta P, Dorsey N J, et al. Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6. J Leukocyte Biol, 2010, 87: 1011-1018
[23]
45 Hebenstreit D, Wirnsberger G, Horejs-Hoeck J, et al. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth F R, 2006, 17: 173-188
[24]
46 Chen H, Sun H, You F, et al. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell, 2011, 147: 436-446
[25]
47 Patel B K, Keck C L, O'Leary R S, et al. Localization of the human stat6 gene to chromosome 12q13.3-q14.1, a region implicated in multiple solid tumors. Genomics, 1998, 52: 192-200
[26]
51 Quelle F W, Shimoda K, Thierfelder W, et al. Cloning of Murine Stat6and Human Stat6, Stat proteins that are tyrosine phosphorylated in responsees to IL-4 and IL-13 but are not required for mitogenesis. Microbiology, 1995, 15: 3336-3343
[27]
52 Patel B K, Wang L M, Lee C C, et al. Stat6 and Jak1are common elements in platelet-dereived growth factor for and interleukin-4 signal transduction pathways in NIH 3T3 fibroblasts. J Biol Chem, 1996, 271: 22175-22182
[28]
56 Ghilardi N, Ziegler S, Wiestner A, et al. Defective STAT signaling by the leptin receptor in diabetic mice. Biochemistry, 1996, 93: 6231-6235
[29]
57 Mathew A, MacLean J A, Dehaan E, et al. Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J Exp Med, 2001, 193: 1087-1096
[30]
1 Takeuchi O, Akira, S. Pattern recognition receptors and inflammation. Cell, 2010, 140: 805-820
[31]
2 Meurs E F, Breiman A. The interferon inducing pathways and the hepatitis C virus. World J Astroentero, 2007, 13: 2446-2454
[32]
5 Horng T, Barton G M, Medzhitov R. TIRAP: An adapter molecule in the Toll signaling pathway. Nat Immunol, 2001, 2: 835-841
[33]
7 Lee M S, Kim Y J. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem, 2007, 76: 447-480
[34]
8 Yamamoto M, Sato S, Mori K, et al. Cutting edge: A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol, 2002, 169: 6668-6672
[35]
9 Yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science, 2003, 301: 640-643
[36]
10 Doyle S E, Vaidya S A, Connell R O, et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Program, 2002, 17: 251-263
[37]
12 H？cker H, Redecke V, Blagoev B, et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature, 2006, 439: 204-207
[38]
13 Meylan E, Curran J, Hofmann K, et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature, 2005, 437: 1167-1172
[39]
14 Kawai T, Takahashi K, Sato S, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated typeⅠinterferon induction. Nat Immunol, 2005, 6: 981-988
[40]
15 Seth R B, Sun L, Ea C K, et al. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell, 2005, 122: 669-682
[41]
16 Xu L G, Wang Y Y, Han K J, et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell, 2005, 19: 727-740
[42]
18 Dixit E, Boulant S, Zhang Y, et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell, 2010, 141: 668-681
[43]
20 Kato H, Takeuchi O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature, 2006, 441: 101-105
[44]
22 Saito T, Hirai R, Loo Y M, et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-Ⅰand LGP2. Proc Natl Acad Sci USA, 2007, 104: 582-587
[45]
26 Moore C B, Bergstralh D T, Duncan J A, et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature, 2008, 451: 573-577
[46]
29 Ishikawa H, Barber G N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature, 2008, 455: 674-678
[47]
30 Zhong B, Yang Y, Li S, et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity, 2008, 29: 538-550
[48]
33 Yan N, Regalado-Magdos A D, Stiggelbout B, et al. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat Immunol, 2011, 11: 1005-1013
[49]
34 Schroder K, Tschopp J. The inflammasomes. Cell, 2010, 140: 821-832
[50]
35 Dotert C, Petrilli V, Broggen R V, et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science, 2008, 320: 674-677
[51]
40 Fernandes-Alnemri T, Yu J W, Datta P, et al. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature, 2009, 458: 509-513
[52]
48 Daniel H, Gerald W, Jutta H H, et al. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth F R, 2006, 17: 173-188
[53]
49 Kashiwada M, Giallourakis C C, Pan P Y, et al. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation. J Immunol, 2001, 167: 6382-6387
[54]
50 Woetmann A, Brockdorff J, Lovato P, et al. Protein phosphatase 2A (PP2A) regulates interleukin-4-mediated STAT6 signaling. J Biol Chem, 2003, 278: 2787-2791
[55]
53 Masuda I B, Matsuguchi T, Yamaki K, et al. Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expression. J Biol Chem, 2001, 276: 26107-26113
[56]
54 Hundley T R, Gilfillan A M, Tkaczyk C, et al. Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood, 2004, 104: 2410-2417
[57]
55 Mascareno E, Dhar M, Siddiqui M A, et al. Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promotor: A cellular signal for hypertrophy in cardiac muscle. Proc Natl Acad Sci USA, 1998, 95: 5590-5594
[58]
58 Van P N, Tang S C, Prout M, et al. In vivo studies fail to reveal a role for IL-4 or STAT6 signaling in Th2 lymphocyte differentiation. Proc Natl Acad Sci USA, 2008, 105: 12423-12428
[59]
59 Jankovic D, Kullberg M C, Noben T N, et al. Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile. J Immunol, 2000, 164: 3047-3055
[60]
60 Chevrier N, Mertins P, Artyomov M N, et al. Systematic discovery of TLR signaling components delineates viral-sensing circuits. Cell, 2011, 147: 853-867
